| HGNC Family | Non-coding RNAs |
| Name | negative regulator of antiviral response (non-protein coding) |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe long noncoding RNA NRAV (negative regulator of antiviral response) has been shown to modulate host–virus interactions. In the context of respiratory syncytial virus (RSV) infection, NRAV expression is significantly downregulated in patients, which appears to be part of the host’s antiviral defense. When overexpressed in respiratory epithelial cells, NRAV facilitates RSV proliferation by indirectly enhancing vesicle transport—specifically by sponging microRNA miR‑509‑3p to relieve repression on Rab5c, a vesicle trafficking protein essential for effective viral uptake and membrane fusion. This implicates NRAV as a key player in modulating the efficiency of viral entry and replication."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nIn hepatocellular carcinoma (HCC), NRAV exhibits oncogenic functions. Elevated NRAV levels in HCC tissues and cell lines correlate with enhanced cell viability, proliferation, and invasion. Mechanistic studies indicate that NRAV acts as a competing endogenous RNA by binding to miR‑199a‑3p, thereby derepressing its target CISD2. The miR‑199a‑3p/CISD2 regulatory axis appears to contribute to the activation of downstream signaling pathways such as Wnt/β‑catenin, further promoting tumorigenic behaviors in liver cells."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, genetic studies in gastric cancer have identified NRAV as one of several lncRNAs whose expression is affected by risk-associated SNPs. Increased NRAV levels, influenced by these genetic variants, have been associated with a higher risk of gastric cancer development. This emerging evidence supports a broader role for NRAV not only in moderating antiviral responses and tumor cell behavior in HCC, but also as a potential biomarker in cancer risk assessment."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jian Li, Miao Li, Xiuli Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.00113-20"}], "href": "https://doi.org/10.1128/JVI.00113-20"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32102886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32102886"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Qingxian Wang, Yumei Tang, Yuansen Ge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA NRAV enhances proliferation and invasion of hepatocellular carcinoma cells by modulating the Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2062977"}], "href": "https://doi.org/10.1080/21655979.2022.2062977"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35436415"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35436415"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yan Zhang, Yun Gao, Fengyuan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA NRAV in the 12q24.31 risk locus drives gastric cancer development through glucose metabolism reprogramming."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgad080"}], "href": "https://doi.org/10.1093/carcin/bgad080"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37950445"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37950445"}]}]}]}
|
| Synonyms | DYNLL1-AS1, DYNLL1AS1 |
| NCBI Gene ID | 100506668 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NRAV has 812 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 11 datasets.
Click the + buttons to view associations for NRAV from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of NRAV gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NRAV gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NRAV gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NRAV gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NRAV gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NRAV gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NRAV gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NRAV gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NRAV gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NRAV gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NRAV gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |